Top compounds associated with response to CCL15-CCL14

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.028	0.4
mRNA	AT-406	CTRPv2	pan-cancer	AAC	-0.039	0.4
mRNA	VU0155056	CTRPv2	pan-cancer	AAC	-0.031	0.4
mRNA	CHIR-99021	CTRPv2	pan-cancer	AAC	0.027	0.4
mRNA	tivozanib	CTRPv2	pan-cancer	AAC	-0.029	0.4
mRNA	BRD-K48477130	CTRPv2	pan-cancer	AAC	-0.045	0.4
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.028	0.5
mRNA	pluripotin	CTRPv2	pan-cancer	AAC	-0.028	0.5
mRNA	prima-1	CTRPv2	pan-cancer	AAC	-0.024	0.5
mRNA	AZD4547	CTRPv2	pan-cancer	AAC	-0.03	0.5

Download CSV